Ginkgo biloba
Jump to navigation
Jump to search
Introduction
- an ornamental tree & the oldest species of tree
- medicinal use has been traced back to the Chinese Materia Medica from 2800 BC
- the German physician Engelbert Kaempfer was the 1st European to catalog Ginkgo in the late 17th century
- it was brought to the US in 1784
- Ginkgo is the most resistant of all trees to infection & pollution
Uses
Current uses:
- symptomatic treatment of cognitive impairment* due to organic brain disease
- peripheral arterial disease*
- headache
- vertigo
- asthma
- tinnitus
- macular degeneration[12]
- no memory benefit for healthy elderly*[7][9][11]
- anxiety (GRS9)[14]; not FDA-approved
* of questionable benefit for cognitive impairment peripheral arterial disease (data conflicting)[16]
Contraindications
Caution:
- discontinue use prior to surgery (1-2 weeks prior)
- avoid in patients with bleeding disorder
- avoid in patients with seizure disorder
Dosage
- standard extract is 24% flavonoid glycosides
- cognitive impairment:
- 120 to 240 mg of dry leaf extract in 2-3 doses
- peripheral arterial disease
- 120 to 1600 mg of dry leaf extract in 2-3 doses
- prevention of cognitive decline post ischemic stroke 450 mg QD[17]
- cognitive impairment:
- capsules 40 mg
- usual dose 40 mg TID
- range 80-240 mg/day
- gingi fluid extract 1:1, 25% alcohol: 1-2 mL TID
- start with low dose & titrate upward to avoid headache
- discontinue 36 hours before surgery[12]
Pharmacokinetics
- at least 8 weeks of treatment for cognitive impairment
- at least 6 weeks of treatment for peripheral vascular disease
- Ginkgo probably induces CYP2C19
Adverse effects
- increase risk for bleeding
- case reports of subarachnoid hemorrhage, subdural hemorrhage & hyphemas
- GI distress (common)
- headache (common)
- use a low dose & titrate upward
- no data on safety during pregnancy
- no toxicity reported with leaf
- skin contact with fruit can cause a poison ivy type syndrome
- seizures (case reports); reduces seizure threshold[10]
- anxiety[12]; used for anxiety (GRS9)[14]
Drug interactions
- potential interaction with anticoagulants*
- potential interactions with antiplatelet agents*
- anticonvulsive agents
- possible interaction with drugs that lower seizure threshold[6][8]
- tricyclic antidepressants (TCA)
- trazodone (Desyrel) in combination may cause CNS depression by overstimulation of GABA receptors[5]
- diminished levels of drugs metabolized by CYP2C19[8]
- ginkgo decreases omeprazole levels & probably other proton pump inhibitors[8]
- MAO inhibitors increase effect & toxicity of ginkgo[12]
- possible interactions with alprazolam, buspirone, efavirenz[16]
* discontinue 36 hours before surgery[12]
Mechanism of action
- active ingredients:
- Ginkgo flavone glycosides & heterosides
- quercetin
- kaempferol
- isorhamnetine
- terpenes
- organic acids
- the leaves are extracted with acetone:water, the organic solvent removed & the extract dried & processed
- Ginkgo flavone glycosides & heterosides
- membrane stabilizing
- free radical scavenger
- enhances cellular uptake & utilization of glucose & O2
- make enhance action of Na+/K+ ATPase
- vasodilation via nitric oxide & prostacyclin
- may enhance venous tone
- inhibits platelet activation, adhesion & degranulation due to direct membrane & antioxidant effects
- increased synthesis of prostacyclin
- antagonist of platelet activating factor (PAF)
- improved rheological properties of blood
- improvement of hypoxic tolerance
More general terms
References
- ↑ Victoria Rand, UCSF Fresno Lecture, 10/7/98
- ↑ Le Bara et al, JAMA October 1997
- ↑ Kleijnen et al, British J Clinical Pharmacology, 1992
- ↑ Kaiser Permanente, Northern California Regional Pharmacy & Therapeutics Committee
- ↑ 5.0 5.1 Prescriber's Letter 7(9):53 2000
- ↑ 6.0 6.1 Prescriber's Letter 9(2):9 2002
- ↑ 7.0 7.1 Journal Watch 22(18):140, 2002 Prescriber's Letter 9(9):53-54 2002 Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA. 2002 Aug 21;288(7):835-40. PMID: https://pubmed.ncbi.nlm.nih.gov/12186600
- ↑ 8.0 8.1 8.2 8.3 Prescriber's Letter 12(9): 2005 Drug Interactions with Ginkgo Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=210910&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 9.0 9.1 DeKosky ST et al Ginkgo biloba for Prevention of Dementia JAMA. 2008;300(19):2253-2262 PMID: https://pubmed.ncbi.nlm.nih.gov/19017911
- ↑ 10.0 10.1 Prescriber's Letter 16(1): 2009 Ginkgo for Prevention of Dementia Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=250103&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 11.0 11.1 Snitz BE et al Ginkgo biloba for Preventing Cognitive Decline in Older Adults. JAMA. 2009;302(24):2663-2670 <PubMed> PMID: https://pubmed.ncbi.nlm.nih.gov/20040554 <Internet> http://jama.ama-assn.org/cgi/content/full/302/24/2663
- ↑ 12.0 12.1 12.2 12.3 12.4 12.5 Geriatrics at your Fingertips, 13th edition, 2011 Reuben DB et al (eds) American Geriatric Society
- ↑ 13.0 13.1 Vellas B, Coley N, Ousset PJ et al Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial Lancet Neurol. 2012 Oct;11(10):851-9. <PubMed> PMID: https://pubmed.ncbi.nlm.nih.gov/22959217 <Internet> http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2812%2970206-5/abstract
- ↑ 14.0 14.1 14.2 Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013
Geriatric Review Syllabus, 9th edition (GRS9) Medinal-Walpole A, Pacala JT, Porter JF (eds) American Geriatrics Society, 2016 - ↑ Hirsch C. Ginkgo biloba extract did not reduce risk for Alzheimer disease in elderly patients with memory complaints. Ann Intern Med. 2013;158(2):JC7 PMID: https://pubmed.ncbi.nlm.nih.gov/23318341
- ↑ 16.0 16.1 16.2 16.3 16.4 Medical Knowledge Self Assessment Program (MKSAP) 17, 18 American College of Physicians, Philadelphia 2015, 2018.
Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025 - ↑ 17.0 17.1 17.2 Li S, Zhang X, Fang Q et al Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial. Stroke Vasc Neurol. 2017 Dec 18;2(4):189-197 <PubMed> PMID: https://pubmed.ncbi.nlm.nih.gov/29507779 Free PMC Article <Internet> http://svn.bmj.com/content/early/2017/11/08/svn-2017-000104